Alpha Tau Medical (NASDAQ:DRTS – Get Rating) and Anika Therapeutics (NASDAQ:ANIK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Alpha Tau Medical and Anika Therapeutics, as reported by MarketBeat.com.
Get Alpha Tau Medical alerts:| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alpha Tau Medical | 0 | 0 | 3 | 0 | 3.00 |
| Anika Therapeutics | 0 | 1 | 1 | 0 | 2.50 |
Alpha Tau Medical currently has a consensus target price of $17.67, indicating a potential upside of 334.07%. Anika Therapeutics has a consensus target price of $28.50, indicating a potential downside of 5.22%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Alpha Tau Medical is more favorable than Anika Therapeutics.
Earnings and Valuation
This table compares Alpha Tau Medical and Anika Therapeutics' top-line revenue, earnings per share and valuation.| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alpha Tau Medical | N/A | N/A | -$27.27 million | N/A | N/A |
| Anika Therapeutics | $147.79 million | 2.97 | $4.13 million | ($1.09) | -27.59 |
Anika Therapeutics has higher revenue and earnings than Alpha Tau Medical.
Profitability
This table compares Alpha Tau Medical and Anika Therapeutics' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alpha Tau Medical | N/A | -49.72% | -33.76% |
| Anika Therapeutics | -10.33% | -2.49% | -2.05% |
Risk & Volatility
Alpha Tau Medical has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.
Institutional and Insider Ownership
1.0% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 91.6% of Anika Therapeutics shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 3.0% of Anika Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Summary
Anika Therapeutics beats Alpha Tau Medical on 6 of the 11 factors compared between the two stocks.
About Alpha Tau Medical
(Get Rating)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
About Anika Therapeutics
(Get Rating)
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.